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Edited by Thomas So¨llnerAbstract Cell–cell fusion is a highly regulated and dramatic
cellular event that is required for development and homeostasis.
Fusion may also play a role in the development of cancer and in
tissue repair by stem cells. While virus–cell fusion and the fusion
of intracellular membranes have been the subject of intense inves-
tigation during the past decade, cell–cell fusion remains poorly
understood. Given the importance of this cell-biological phenom-
enon, a number of investigators have begun analyses of the
molecular mechanisms that mediate the specialized fusion events
of a variety of cell types and species. We discuss recent genetic
and biochemical studies that are beginning to yield exciting in-
sights into the fusion mechanisms of Saccharomyces cerevisiae
mating pairs, Caenorhabditis elegans epithelial cells and ga-
metes, Drosophila melanogaster and mammalian myoblasts,
and mammalian macrophages.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Caenorhabditis elegans; Drosophila melanogaster1. Cell–cell fusion: a specialized form of membrane fusion
A cell, the basic unit of life, is deﬁned by a plasma mem-
brane. Membranes are central to the origin, the diﬀerentiation
and the function of all cells. Membranes are lipid bilayers that
also form intracellular compartments, which undergo constant
fusion and ﬁssion to regulate molecular traﬃcking between
organelles, between cells and their extracellular milieu, and be-
tween neighboring cells. To fuse with one another, membranes
incorporate proteins as intrinsic recognition devices that secure
the speciﬁcity and the eﬃcacy of fusion. While intracellular
membrane fusion depends on a-helical bundle structures simi-
lar to those used by many viruses to fuse with cells during
infection, the mechanisms that mediate fusion of pairs and
groups of cells remain poorly understood. Here we discuss
our current knowledge about the mechanisms in a variety of*Corresponding author. Fax: +1 203 737 2701.
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doi:10.1016/j.febslet.2007.03.033species (yeast, nematodes, arthropods, and mammals) and cell
types (gametes, epithelia, myoblasts, and macrophages). We
have learned that although cell–cell fusion events are cell-type
speciﬁc, they may share some mechanistic similarities.2. Yeast mating
Yeast cells fuse when they mate (Fig. 1). Genetic studies of
mating in the yeast Saccharomyces cerevisiae began over 30
years ago with the isolation of sterile (ste) mutants [1,2], plac-
ing yeast mating among the most intensively studied cell fusion
processes.
S. cerevisiae has two mating types (sexes), MATa and
MATa. Mating initiates with an exchange of pheromone sig-
nals between cells of the opposite mating type. MATa cells re-
lease the a-factor pheromone, which binds to a G-protein
coupled receptor expressed exclusively on MATa cells, and
vice versa. The pheromone receptors activate a common
MAP kinase signaling pathway resulting in three key re-
sponses: (1) the cell cycle arrests in G1 to insure that both cells
have exactly one copy of each chromosome before they fuse;
(2) cells reorient their growth axis to form a mating projection
in the direction of a potential mate, and (3) transcription of
mating genes is induced. This signal transduction pathway
has served as a paradigm for signaling studies in diverse sys-
tems, and has been the subject of several comprehensive re-
views [3,4]. In brief, the pheromone receptors Ste2 and Ste3
are linked to a G-protein complex containing Gpa1 (Ga),
Ste4 (Gb) and Ste18 (Gc). The bc subunits released upon pher-
omone binding activate the Ste20 PAK kinase and initiate the
recruitment of a signaling complex that includes the MAP ki-
nase scaﬀold Ste5 [5]. Ste5 recruits Ste11, Ste7 and Fus3, the
three kinases of the pheromone signaling MAP kinase cascade,
and brings the MAPKKK Ste11 into contact with the Ste20 ki-
nase to promote Ste11 phosphorylation. Among the targets of
the MAPK Fus3 are the transcription factor Ste12, which
binds to pheromone response elements localized at the 5 0 of
pheromone-induced genes, the formin Bni1, which stimulates
polarized assembly of actin cables within mating projections,
and the cyclin-dependent kinase inhibitor Far1, which acts
within the nucleus to arrest the cell cycle and is also translo-
cated to the plasma membrane to aid in polarity establishment
[6,7].blished by Elsevier B.V. All rights reserved.
Fig. 1. Stages of the yeast mating process and genes that participate in each stage.
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action between cell surface glycoproteins whose expression is
induced by mating pheromones [8]. The a-agglutinin Sag1 con-
tains three immunoglobulin-like domains. The a-agglutinin
has two subunits: the smaller subunit Aga2 contains a Sag1
binding site, while the larger subunit Aga1 anchors the com-
plex to the cell wall and stabilizes Aga2 in a binding conforma-
tion. The mating agglutinins are initially synthesized as GPI-
anchored proteins and are then transferred to the cell wall
by a transglycosylation reaction. However, an engineered form
of Aga1 retained some activity after replacing its transmem-
brane domain with a GPI-anchor [9]. The agglutinins are
essential for mating in aerated liquid cultures, where agitation
produces sheer forces that oppose mating pair assembly, but
are unnecessary for mating on a solid surface [10]. Thus, un-
known low-aﬃnity interactions are likely to complement
agglutinin-mediated binding.
The cell walls of the two cells in a mating pair must be
remodeled before the underlying plasma membranes can come
into contact and fuse. Cell wall assembly defects typically lead
to osmotic lysis. Yeast avoid osmotic lysis during mating by
ﬁrst assembling a unifying wall surrounding the junction and
then selectively degrading the cell wall at the contact site. This
carefully orchestrated process depends upon robust phero-
mone signaling and a set of cell polarity regulators and phero-
mone-induced genes (Fig. 1). The common phenotype found
when these genes are mutated is an accumulation of arrested
prezygotes that have cell wall separating the two plasma mem-
branes [11,12]. In the fus2 and rvs161 mutants, small vesicles
accumulate on either side of the intercellular junction [12].These presumptive secretory vesicles are thought to deliver
hydrolytic enzymes for cell wall remodeling and might also
contain membrane proteins required for cell fusion.
Once cell wall remodeling is complete, osmotic gradients
across the two plasma membranes drive them into tight appo-
sition. If cytoplasmic osmolarity diﬀers between the two cells,
the cell with higher osmolarity can extend a ﬁnger of
membrane bound cytoplasm into its mating partner [13,14].
Cytoplasmic ﬁngers are rarely observed prior to fusion in
wild-type mating, suggesting that plasma membrane fusion
typically occurs shortly after membrane contact is achieved.
Mitotic yeast cells treated with lyticase to remove their cell
walls almost never fuse when their plasma membranes are
manipulated into contact. Thus, the membrane fusion machin-
ery is likely to be induced during mating.
Plasma membrane fusion is regulated by PRM1, a gene dis-
covered in a bioinformatic screen for pheromone-inducible
membrane proteins [13]. PRM1 is not essential for mating,
since 25% of Dprm1 mating pairs are able to fuse. Further-
more, cell fusion defects are only observed when PRM1 is
mutated in both mating partners. The deﬁning phenotype of
prm1 mutants is an accumulation of arrested mating pairs with
plasma membranes that are in contact, but unfused [13]. A sec-
ond informative phenotype is simultaneous lysis of the two
cells in a mating pair immediately after their plasma mem-
branes come into contact [14]. In the absence of Prm1, uncoor-
dinated fusion protein activity is thought to rupture the two
plasma membranes instead of fusing them. Mutations in
FIG1, a gene encoding another pheromone-induced membrane
protein, lead to a lesser degree of membrane fusion arrest and
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is increased in the absence of extracellular Ca2+ or by mutation
of Tcb3, a membrane protein with three cytoplasmicly oriented
C2 Ca2+ binding domains, suggesting that Ca2+ inﬂux through
a pre-lytic pore can activate a plasma membrane repair path-
way. A similar mechanism might underlie the contribution of
myoferlin to mouse myoblast fusion [16].
A fusion pore is the ﬁrst aqueous connection between two
membranes. Fusion pore opening and expansion can be mea-
sured by following the rate of GFP transfer between cells
[17]. The fusion pore of a typical yeast mating pair opens sud-
denly and then gradually expands, but the initial opening is
reversible. The size and expansion rate of the pore is regulated
by Fus1, a membrane protein concentrated at sites of intercel-
lular interaction that had been previously implicated in cell
wall remodeling [17]. Fus1 has both genetic and physical inter-
actions with a web of proteins implicated in cell polarity and
fusion, suggesting that it may be an integrative regulator of
the cell fusion process [18].
Once the plasma membranes of two yeast cells have fused,
mating is completed by merger of the two nuclei in a process
termed karyogamy [19]. Karyogamy does not occur in most
developmental fusions, but it has been observed in syncytia
resulting from HIV infections [20]. Nuclear congression, the
ﬁrst stage of karyogamy, is microtubule-dependent. The dy-
namic plus ends of microtubules emanating from the spindle
pole body are transported by Myo2 along actin ﬁlaments
and maintained at sites of intercellular contact by Bim1 and
Kar3 [21]. After plasma membrane fusion, oppositely oriented
microtubules from the two cells interact at their plus ends
through Kar3 and Bik1 and depolymerize to pull the nuclei to-
gether [22]. The nuclear envelopes each have two lipid bilayers.
The outer layer is contiguous with the ER, and its fusion is
likely to involve ER localized SNAREs including Ufe1. How-
ever, the atypical SNARE disassembly factor Cdc48 is re-
quired in place of Sec18/NSF [23]. Furthermore, mutations
in luminal ER proteins including the chaperone Kar2 and
the translocon-associated proteins Sec63 and Sec70/71 also in-
hibit fusion of the outer nuclear envelope [24].
The ﬁnal product of yeast cell fusion is a peanut-shaped zy-
gote with a diploid nucleus. The cell cycle then resumes and
diploid daughter cells bud oﬀ from the neck connecting the
two parent cells. This transition is facilitated by Asg7, a
MATa-speciﬁc cytoplasmic protein that enters the MATa cell
after fusion to trigger Ste4 down regulation, thereby terminat-
ing the pheromone response and limiting cell fusion to a single
pair of cells [25].
Although the preceding section provides only a broad over-
view of such thoroughly investigated processes as pheromone
signaling and polarized morphogenesis, much remains to be
learned about other aspects of mating. For example, little is
known about how yeast recognize that they have formed a
mating pair and signal that it is safe to proceed further on
the mating pathway. Given the variety of screens that have
been conducted for mating defective yeast, perhaps the biggest
surprise is that the underlying mechanism of plasma mem-
brane fusion remains largely unknown. Since fusion proteins
in other systems typically form complexes with other proteins
that participate in the fusion process, the best hope for identi-
fying core components of the cell fusion machinery may be to
screen for genes and proteins that interact with the three
known components Prm1, Fig1 and Fus1.3. Somatic cell and gamete fusion in nematodes
Syncytial cells form in a variety of tissues within nematodes,
by cell–cell fusions that occur during progressive stages of
development from the embryo to the mature adult. More than
30% of the 959 somatic nuclei in an adult hermaphrodite of
Caenorhabditis elegans reside in multinucleate cells, in tissues
ranging from neuronal support (glial) cells, to epidermal and
internal epithelia, to contractile muscle [26]. Interestingly,
although skeletal muscle is consistently syncytial in arthropods
and vertebrates, the body-wall musculature responsible for
motility of C. elegans is made up of only mononucleate cells.
The pumping-swallowing muscles of the pharynx, however,
comprise 13 coherent and precisely arranged syncytia [27].
Some evidence suggests that at least one mononucleate neuron
may even form a ring-shaped process by fusion of distinct
axons (W. Mohler and D. Hall, unpublished observations
from original data of Albertson and Thomson [27]). Many
cell–cell fusions yield binucleate cells, but several larger syncy-
tia also form. One prominent case is an epidermal giant cell
that grows via sequential waves of new fusions with mono-
nucleate partners, from 2 nuclei (in mid-embryogenesis), to
23, to 46, to 74, to 112, to a ﬁnal total 138 nuclei. In all
instances, the ancestries and identities of each pair of fusion
partner cells are invariant from specimen to specimen, and
the timing of the fusion events is predictable.
Multinucleate cells were ﬁrst characterized by groups that
determined the full cell lineage of C. elegans, using both light
and transmission electron microscopy (TEM) [28,29]. The con-
clusion that syncytia form by fusion was supported by the
observation that cells with quite distinct ancestries in the line-
age (not simply sisters) could contribute nuclei to the same
syncytium. Subsequently, the use of cell-junction markers –
by monitoring their disappearance – permitted observation
of the relative timing of individual fusion events [30–32]. Mul-
tidimensional imaging in combination with a plasma-mem-
brane dye, GFP-labeled markers, and TEM has since
revealed fusion events progressing via widening of a single
aperture through the two cell membranes [33]. Membrane mer-
ger and cytoplasmic continuity between cells actually occur
several minutes before intercellular junctions vanish.
Genetic screens for disruption of cell fusions in the develop-
ment of the epidermis and vulva have repeatedly yielded reces-
sive mutations in the gene eﬀ-1 [34]. Inactivation of eﬀ-1 leaves
epithelial diﬀerentiation, migration, cell shape, and cell–cell
contact unaﬀected, allowing embryonic morphogenesis to pro-
ceed almost entirely normally. However, most cell fusions in
eﬀ-1 mutants are blocked in the initial step of membrane per-
meabilization; intact cell borders and intercellular junctions re-
main within ﬁelds of neighboring cells that would normally
become completely fused. Yet, not all cell types are blocked
in fusion by eﬀ-1 mutations, among them sperm and eggs
[35,36]. Null mutants in eﬀ-1 ultimately acquire a severely
abnormal morphology as postembryonic development pro-
gresses, but they remain fertile and viable in laboratory cul-
ture. This viability, combined with a penetrant phenotype,
aided in the cloning of eﬀ-1.
The eﬀ-1 gene encodes both single-pass integral membrane
proteins and secreted isoforms, via alternative splicing, and
eﬀ-1 expression is induced in fusion-fated cells shortly before
fusion occurs [34]. Recent experiments have shown that forced
expression of eﬀ-1 can induce fusion of normally non-fusing
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ity appears to be speciﬁc to the integral-membrane protein iso-
forms EFF-1A and EFF-1B [36–38]. Yet, the rate of fusion can
be enhanced in vitro by presence of a soluble extracellular frag-
ment of EFF-1 [38], suggesting a physiological signiﬁcance for
the naturally occurring secreted isoforms encoded by the eﬀ-1
locus. Additionally, observation of both mixed cell cultures
and genetic mosaic animals show that each cell in a pair of fu-
sion partners must express membrane-bound EFF-1 in order
to fuse [37,38]. In keeping with this requirement of mutual
expression, observation of ﬂuorescently tagged EFF-1::GFP
in nematode embryos indicates that EFF-1 is predominantly
retained in intracellular pools, accumulating at the plasma
membrane only where there is direct contact between two
EFF-1-expressing cells [36]. This suggests, among other possi-
bilities, that EFF-1 may act as its own receptor allowing a sim-
ple homotypic interaction to deﬁne the propriety of a pair of
neighboring cells for fusion.
EFF-1 currently stands as a prototype for developmentally
regulated cellular fusogens; to date, no other membrane pro-
teins have been shown to be both necessary and suﬃcient to
induce fusion competence in development. Another C. elegans
gene, C44B7.3, encodes a paralogue of EFF-1 [34]. However,
although eﬀ-1 and C44B7.3 are very highly conserved among
nematodes, recognizable homologues have not been found in
the sequenced genomes of fungi, arthropods, or vertebrates.
Interestingly, the strongest candidates for developmentally reg-
ulated cellular fusogens in mammals are the placental syncy-
tins of primates and rodents, clear homologues of retroviral
envelope fusogens [39,40]. Understanding the biophysical
mechanism of syncytin fusogenicity will likely parallel the pro-
gress in understanding of membrane fusion in viral infection.
In contrast, EFF-1 bears only a rough likeness (but no se-
quence similarity) to the overall structure of known viral fu-
sion proteins, and it stands out as distinct from known viral
fusogens by virtue of its homotypic mode of action [38].Fig. 2. Model portraying several aspects of EFF-1 function in patterning c
fusion-partner-speciﬁc EFF-1 re-localization to the plasma membrane and su
remain unfused.Even though EFF-1 appears to act autonomously in induc-
ing fusion, other gene products must regulate its action to yield
such a reproducible pattern and sequence of fusion events. Ge-
netic analysis has revealed that loss of function in components
of the vacuolar H+-ATPase (V-ATPase) complex causes ecto-
pic fusions to occur beyond the limits of normal syncytia in the
embryo [41]. This abnormal fusion depends upon eﬀ-1 activity,
and the V0 complex is involved in secretion in other species
[42,43]. This suggests that the V-ATPase complex may coordi-
nate or focus EFF-1 function by targeting transport to speciﬁc
fusion contacts. Another possibility for this interaction could
be indirect: a defect in secretion of extra cellular matrix com-
ponents may weaken fusion-blocking boundaries that appear
to separate tissues during morphogenesis [36].
Whether to fuse or to remain an individual is a critical cell
fate decision made by many cells during the development of
the worm. Sister cells from a new cell division often opt for
opposite choices shortly after they are born. Because cell fu-
sion is a process integral to the development of several well-
studied tissues and lineages (e.g. the vulva, the seam cells), a
number of genes have been identiﬁed as critical to the decision
to adopt a fusion fate; see a full review in ref [26]. Many of
these are transcription factors that presumably regulate expres-
sion of fusogenic genes like eﬀ-1 or of fusion inhibitors like
V-ATPase. In the case of eﬀ-1, deletion analysis and reporter
assays indicate that regulatory sequences comprise several sep-
arate enhancers distinctly tuned to activate transcription in
speciﬁc tissues and at speciﬁc times in development [44].
As mentioned above, eﬀ-1 mutations do not block fertiliza-
tion, so other mechanisms must drive sperm–egg fusion in the
worm. Genetic studies of C. elegans fertility mutants suggest
that they also diﬀer frommammalian sperm in their mechanism
of sperm–egg fusion. Three sperm-expressed proteins, SPE-9
(an EGF-repeat containing membrane protein), TRP-3/SPE-
41 (a TRPC-type calcium channel), and SPE-38 (a novel tetra-
span membrane protein), are required speciﬁcally for spermell fusions. Homotypic contacts between eﬀ-1-expressing cells induce
bsequent cell membrane fusion. Neighboring cells not expressing eﬀ-1
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in any of the three genes yields sperm that activate and migrate
normally but fail to fertilize eggs. TRP-3 is interesting, as its
involvement seems to parallel the action of murine Trp2 chan-
nel in triggering the sperm acrosome reaction [50,47]. SPE-38,
although containing four membrane spanning domains, does
not encode a homologue of the mammalian CD9, and its struc-
tural similarity to yeast Prm1 is currently unclear [45].
Clearly much remains to be solved in understanding the fu-
sion of somatic and gametic cells in nematodes, but some
important lessons can already be inferred from the current
knowledge. First, developmental fusogen mechanisms – e.g.,
the homotypic and suﬃcient case of EFF-1 – may be as simple
as viral fusogen complexes, or possibly even simpler. Second,
the deployment of a single simple fusion machine may be gov-
erned by complex regulatory inputs to induce precise fusions in
many diﬀerent tissues and diﬀerent moments of development.
Third, from EFF-1’s lack of conservation between phyla, we
can be fairly certain that more than one family of fusogenic
proteins must drive cell fusions throughout Eukaryota. But
how many families of cellular fusogens there are, and whether
diﬀerent clades of species or lineages of cells tend to employ
unique proteins to drive cell fusion, can only be answered by
ﬁnding the critical proteins in other model systems.
As to the physicochemical mechanism of action of EFF-1,
much remains unknown. Is EFF-1 its own receptor? (see
Fig. 2) Does it employ a virus-like fusion peptide to form
membrane pores? The path to this level of understanding lies
in a transition from largely genetic and cell-biological experi-
ments to biochemistry, structural biology, and biophysics.
Yet, the strengths of the nematode as a truly in vivo experimen-
tal system should remain critical in validating insights gained
from experiments on the protein in isolation.4. Myoblast fusion
Skeletal muscle is a unique organ that is composed of bun-
dles of multinucleate muscle ﬁbers. Each muscle ﬁber, or cylin-
drical muscle cell, is the product of fusion of hundreds, or even
thousands, of myoblasts. Myoblast fusion during vertebrate
embryogenesis occurs in two phases. Initially, myoblasts fuse
with one another to form nascent myotubes with a small num-
ber of nuclei. This is followed by additional rounds of fusion
between myoblasts and nascent myotubes, resulting in the for-
mation of large, mature myotubes [51]. During late embryo-
genesis, a population of myoblasts, known as satellite cells,
are set aside and will later become adult muscle stem cells. Sa-
tellite cells are able to proliferate, diﬀerentiate and fuse with
existing muscle ﬁbers or to form new ﬁbers during postnatal
growth, regeneration and maintenance of skeletal muscle [52].
A number of molecules have been implicated in the initial fu-
sion between myoblasts by in vitro myoblast culture assays.
Among these are cell adhesion molecules, metalloproteases,
calcium and calcium-binding proteins, lipids and phospholipa-
ses, all of which have been the subject of excellent reviews and
will not be further discussed here [51,53–55]. Recent studies
using myoblast culture assays in combination with mouse
knock-out models have begun to uncover molecules that regu-
late fusion of myoblasts with nascent myotubes (reviewed by
[51]) (Table 1). In particular, studies of calcium signaling inmammalian muscle growth have revealed components of the
NFATC2 pathway in the second phase of fusion. These in-
clude the transcription factor NFATC2, an activator of the
pathway (prostaglandin F2a or PGF2a) and a secreted molecule
regulated by NFATC2 (interleukin-4 or IL-4) [56–58]. A
potentially parallel pathway to that of NFATC2 is mediated
by the mammalian target of rapamycin (mTOR), which in turn
may regulate the secretion of another unknown factor that is
essential for myoblast–myotube fusion [59]. Additional mole-
cules that play a role in the second phase of fusion include
the C2 domain-containing transmembrane protein, myoferlin,
which is involved in binding calcium-sensitive phospholipids
[16], and the secreted protein follistatin, which is activated
by deacetylase inhibitors to induce muscle growth [60]. Re-
cently, mannose receptor, another transmembrane protein,
has been shown to be required in directed cell migration lead-
ing to myoblast–myotube fusion [61].
Compared to in vitro assays used to analyze mammalian
myoblast fusion, the fruit ﬂy Drosophila oﬀers a great in vivo
system to study this process. Unlike the mammalian skeletal
muscle that takes days and weeks to generate, the somatic
musculature of Drosophila develops within hours during
embryogenesis, and each of the 30 muscle ﬁbers in a hemi
segment of a ﬂy embryo is a product of fusion between only
3 to 25 myoblasts [62]. In addition, the cellular events of recog-
nition, adhesion, alignment and membrane merger are con-
served during myoblast fusion in Drosophila embryos,
making the ﬂy somatic musculature an amenable system to dis-
sect myoblast fusion under physiological conditions.
In Drosophila, myoblast fusion occurs between two types of
muscle cells, muscle founder cells and fusion competent myo-
blasts [63]. Muscle founder cells reside in a mesodermal layer
that is close to the ectoderm, whereas the pool of fusion com-
petent myoblasts occupies several deeper cell layers in the em-
bryo, close to the endoderm. The identities of the two cell
types are speciﬁed by a cascade of transcription factors (re-
viewed in [64]). While subsets of muscle founder cells express
diﬀerent ‘‘selector genes’’, all fusion competent myoblasts are
speciﬁed by a single transcription factor, Lame duck (also
know as Myoblast incompetent and Gleeful) [65–67]. During
myoblast fusion, muscle founder cells attract fusion competent
myoblasts, which migrate and extend ﬁlopodia toward foun-
der cells, followed by adhesion and fusion between the two
populations of cells. Analogous to vertebrate myogenesis,
myoblast fusion in Drosophila also occurs in two phases.
While the initial phase of fusion yields bi- or tri-nucleate mus-
cle precursors, the second phase of fusion gives rise to multi-
nucleate muscle ﬁbers with distinct position, orientation and
size [68].
Ultrastructural analyses have revealed fascinating details of
Drosophila myoblast fusion [69]. Paired vesicles with electron
dense margins are observed along the apposed membranes be-
tween founder and fusion competent myoblasts. Little is
known about the origin of the vesicles, their biochemical com-
position and their function during myoblast fusion. These ves-
icles presumably resolve into elongated electron-dense plaques
along the two membranes. Subsequently, small membrane dis-
continuities (fusion pores) form, which lead to the mixing of
the cytoplasm and fusion of the two cells. It is worth noting
that the presence of multiple fusion pores along apposing myo-
blast membranes is in contrast to the formation and expansion
of a single fusion pore between yeast and C. elegans fusion
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2186 E.H. Chen et al. / FEBS Letters 581 (2007) 2181–2193partners [17,33]. Nevertheless, the signiﬁcance of these fusion
intermediates (vesicle, plaque, pore) in Drosophilamyoblast fu-
sion is underscored by their absence in various fusion mutants
[69].
Genetic and molecular studies in the last decade have yielded
signiﬁcant insights into the mechanisms underlying myoblast
fusion in Drosophila (reviewed in [69,70]) (Fig. 3). An impor-
tant early discovery is that recognition and adhesion between
muscle founder cells and fusion competent myoblasts are
mediated by immunoglobulin (Ig)-domain containing trans-
membrane proteins. In founder cells, two such proteins,
Dumbfounded (Duf; Also known as Kirre) and Roughest
(Rst; Also know as Irre-C), are both expressed and play redun-
dant functions to attract fusion competent myoblasts [71,72].
Fusion competent myoblasts also express two Ig-domain con-
taining transmembrane proteins, Sticks and stones (Sns) and
Hibris (Hbs), with Sns required for fusion and Hbs modifying
the activity of Sns [73–75]. Expression of full length or mem-
brane-anchored forms of these transmembrane proteins in
Drosophila cultured cells results in cell adhesion without mem-
brane fusion, suggesting that these proteins are not suﬃcient to
induce cell fusion in a heterologous system [76]. In contrast,
expression of the membrane anchored Duf extracellular do-
main (Duf-TM-EC) in the developing mesoderm enables the
ﬁrst phase of fusion in duf, rst double mutant embryos, result-
ing in bi-nucleate muscle precursors [77]. It remains to be
determined if the discrepancy between in vivo and cell culture
studies is due to the speciﬁc spatial arrangement of myoblasts
in vivo, or ectopic expression of a founder cell-speciﬁc adhesion
molecule (Duf-TM-EC) in fusion competent myoblasts, or
other unknown fusion regulator(s) speciﬁcally present in vivo.
While the extracellular domains of the fusion receptors are
required for myoblast recognition and adhesion, the cytoplas-
mic domains of these proteins recruit multiprotein complexes
to the membrane, in order to induce additional rounds of fu-
sion and, eventually, generate multinucleate muscle ﬁbers. In
founder cells, the Duf receptor recruits an adaptor protein
Antisocial (Ants; Also known as Rols7) to sites of fusion
[78,79]. Ants contains several potential protein–protein inter-
action motifs, including ankyrin repeats, tetratricopeptide re-
peats (or TPRs) and a coiled-coil domain, making it a likely
candidate as a scaﬀolding protein. In support of this, Ants
interacts with a cytoskeleton-associated protein, Myoblast city
(Mbc) [80], thus linking the Duf receptor with downstream sig-
naling components [78]. Mbc is the Drosophila homologue of
the mammalian protein, DOCK180, which was ﬁrst identiﬁed
as a major binding partner for the SH2/SH3 domain-contain-
ing adaptor protein Crk [81]. Although loss-of-function muta-
tions in Drosophila Crk are not yet available, overexpressing a
membrane-targeted form of Crk caused a fusion defect, imply-
ing a function of Crk during myoblast fusion [69]. However,
recent studies show that the interaction between Mbc and
Crk is not required to bring Mbc to sites of fusion, nor is it re-
quired for Mbc’s function in vivo, suggesting that Crk may af-
fect fusion by interacting with other proteins [82].
Interestingly, DOCK180 is an unconventional guanine nucleo-
tide exchange factor (GEF) [83] for the small GTPase, Rac,
which is an important regulator of the actin cytoskeleton
and is also required for myoblast fusion [84,85]. Thus, the
Dufﬁ AntsﬁMbcﬁ Rac pathway is required in founder
cells to transduce fusion signal from the membrane to the actin
cytoskeleton.
Fig. 3. A model describing signal transduction during myoblast fusion. Proteins that have been characterized in myoblast fusion are shown in red,
and others are in purple. Solid arrows indicate demonstrated interactions and dashed ones indicate the existence of potential intermediary proteins.
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blast fusion? Previous studies have shown that Rac acts as a
positive regulator of actin polymerization through a Wiskott-
Aldrich syndrome protein (WASP) family member, WASP-
family verprolin-homologues (WAVE) (also know as Scar in
Drosophila) [86,87]. WAVE is present in a ﬁve-protein complex
(WAVE complex) that include four other proteins, Nap1 (also
know as Kette in Drosophila), Sra1/PIR121, Abi and
HSPC300, each of which has been associated with cytoskeletal
function [88]. The WAVE complex could be involved in
WAVE localization or inhibition of WAVE’s activity, the lat-
ter of which is antagonized by Rac activation [89]. Interest-
ingly, one of the components of the WAVE complex, Kette,
is also required for myoblast fusion [90] suggesting that Rac
may act through the WAVE complex to regulate Scar activity
during the fusion process. Kette has also been shown to genet-
ically interact with a PH-domain containing protein, Blown
fuse (Blow) which is necessary for fusion [69]. However, the
speciﬁc function of Blow in myoblast fusion remains unknown.
Besides the Dufﬁ AntsﬁMbcﬁ Racﬁ Scar pathway,
Duf also recruits Loner, a Sec7 domain containing GEF for
the small GTPase Arf6, through an unknown intermediary
protein(s) to sites of fusion [91]. The Lonerﬁ Arf6 module
is independent of the AntsﬁMbcﬁ Racﬁ Scar pathway,
but is required for the proper localization of Rac [91]. Thus
the two pathways converge at the small GTPase Rac and are
both involved in transducing the fusion signal to the actin
cytoskeleton. It is formally possible that the Lonerﬁ Arf6
module performs additional functions other than localizing
Rac, given that Arf6 also plays a role in lipid modiﬁcation
and vesicle traﬃcking [92].Less is known about the signal transduction events in fusion
competent myoblasts. Several proteins that are required for fu-
sion are expressed and/or required in both cell populations,
including Mbc and Kette [82,90], suggesting that the actin
cytoskeleton in fusion competent myoblasts also undergoes
rearrangements during fusion. It remains to be determined if
signal transduction from the membrane receptor Sns to the ac-
tin cytoskeleton is mediated by fusion competent cell-speciﬁc
protein(s), as in founder cells.
It appears that all signaling events in myoblast fusion uncov-
ered to date lead to remodeling of the actin cytoskeleton. Based
on the cellular phenotypes of myoblasts in various fusion mu-
tants, it is likely that the actin cytoskeleton may perform multi-
ple functions during myoblast fusion. First, actin cytoskeletal
rearrangement is likely to be involved in myoblast migration
and ﬁlopodia formation. This is supported by the presence of
a large number of round-shaped fusion competent myoblasts
in deeper layers of embryos mutated for either mbc or rac
[63,84]. Second, the actin cytoskeleton may play a role in a later
step during myoblast fusion, after cell recognition and adhe-
sion, since mutations in certain upstream regulators of the actin
cytoskeleton do not aﬀect myoblast attachment [78,79,91].
What is the precise function of the actin cytoskeleton following
myoblast adhesion? Could it be involved in transporting
fusion-related vesicles, if they are of exocytic origin, to sites
of fusion? Could it serve as a scaﬀold to stabilize plasma mem-
brane interactions? Or could it directly impact lipid mixing by
producing mechanical strain, or even inducing/expanding
breaks, on the lipid bilayers? Answers to these questions await
future investigations that will provide unprecedented insights
into the mechanisms of myoblast fusion in ﬂies and in human.
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In contrast with most fusing cell types, which undergo fusion
as a required part of their developmental program, macro-
phages fuse rarely and reside in tissues as mononucleate cells.
Macrophages fuse in speciﬁc and rare instances to form new
cells, which are osteoclasts and giant cells. This indicates that
the fusion of macrophages is a tightly controlled event. Like
most other fused cells, except for sperm–oocyte fusion and
yeast mating, their nuclei keep their integrity within a shared
cytoplasm.
Macrophages are mononucleate cells that belong to the mye-
loid lineage. They are ubiquitously present in tissues, in which
they adjust to local tissue environment and physiology to se-
cure homeostasis and repair. So macrophages ‘‘wear many
hats’’ and are true ‘‘cells without borders’’, characterized by
mobility, plasticity and adaptability. In some respects, macro-
phages appear as primitive nurturing cells that have main-
tained their ‘‘independence’’ and reﬁned their ‘‘social
support’’. While macrophages have long been regarded as
the ‘‘tissue cleaners’’, they are now recognized as highly sophis-
ticated entities, many of whose functions remain to be discov-
ered. In speciﬁc and rare instances, macrophages are attracted
to one another and fuse to form multinucleate osteoclasts in
bone, or giant cells in chronic inﬂammatory sites. Macro-
phages have evolved a mechanism to augment their size, but
why would macrophages increase their number of nuclei?
Why cannot macrophages work together as a team without
having to fuse? This is a question that is central to the evolu-
tion of the skeleton and of the innate/adaptive immune system,
via osteoclasts and giant cells, respectively.
Multinucleation has two main eﬀects on macrophages: it in-
creases their size and, consequently, it endows them with the
ability to resorb large components that cannot otherwise be
internalized by a single cell. The number of nuclei that multi-
nucleate macrophages contain appears to be proportional,
hence adapted, to the size of the target/foreign body they re-
sorb. Instead of internalizing a target, such as a bacterium,
and routing it to lysosomes for degradation, multinucleation
allows macrophages to degrade components extracellularly.
Multinucleate macrophages attach ﬁrmly to their target via a
sealing zone, a ring that seals oﬀ an extracellular compartment
(reviewed by [93]). The content of this compartment has a low
pH that facilitates the dissolution (e.g. bone), or killing (e.g.
pathogens) of the target, and the activation of lysosomal en-
zymes. Hence it is considered an ‘‘extracellular lysosome’’.
Multinucleation endows macrophages with an enhanced
capacity, meaning that two macrophages cannot do what
one binucleate macrophage does. Hence, multinucleate macro-
phages are more than the sum of their parts. This capacity is
best illustrated by the vast array of genes that are diﬀerently
regulated during osteoclastogenesis (reviewed by [94]). Indeed,
multinucleation is an essential step in the diﬀerentiation of
osteoclasts as mononucleate macrophages cannot resorb bone
eﬃciently. This happens in diseases in which macrophages can-
not fuse, such as in some forms of osteopetrosis where bones
are thick and brittle.
As to the fate of osteoclasts, it is sad to say that their half-life
is about three days, hence considerably shorter than that of
monocytes and macrophages, which can be measured in
months. Osteoclasts are therefore potent destroyers that have
a full-blown life, but at a high price. However, the half-lifeof giant cells might be longer, if we assume that they remain
alive within granulomas, which are long-lived entities.
It is now well accepted that bone marrow-derived macro-
phages and monocytes be activated by the cytokines RANKL
to diﬀerentiate into osteoclasts, and IL-4 to form giant cells
(reviewed by [95,96]). This is in addition to the growth factors
M-CSF and GM-CSF, which secure their growth and their
survival. It is interesting to note that IL-4 promotes the diﬀer-
entiation of both multinucleate giant cells and myoblasts,
which occurs via an autocrine mechanism [56]. Surprisingly,
IL-4 prevents the diﬀerentiation of multinucleate macrophages
into osteoclasts, which suggests that IL-4 activates speciﬁc sets
of genes that might be adapted to chronic inﬂammation [97].
Nevertheless, while RANKL is required for the formation of
osteoclasts in vivo, the requirement for IL-4 to form giant cells
in vivo remains open. In addition, the chemokine MCP-1,
which promotes the migration of macrophages, stimulates
the formation of both mouse giant cells in vivo and human
osteoclasts in vitro [98,99].
Components of the putative machinery that mediates the fu-
sion of macrophages were identiﬁed initially using monoclonal
antibodies that both recognized cell surface determinants and
altered fusion in tissue culture. The ﬁrst protein identiﬁed by
antibodies that blocked fusion of macrophages in vitro was
designated macrophage fusion receptor (MFR), now called
SIRPa [100–104] because of its structural resemblance to
CD4, the cell surface receptor for HIV infection. Like CD4,
MFR/SIRPa is a plasma membrane protein that belongs to
the superfamily of immunoglobulins (IgSF) and contains three
extracellular Ig loops. Subsequently, MFR/SIRPa was shown
to bind CD47, which also belongs to the IgSF, and the recom-
binant soluble extracellular domains of both MFR/SIRPa and
CD47 were reported to block fusion in culture. While CD47
expression is ubiquitous, that of MFR is restricted to myeloid
cells and neurons. In addition, MFR/SIRPa expression is
strongly but transiently induced at the onset of fusion in mac-
rophages while that of CD47 remains constant, further sug-
gesting that fusion is a regulated event. CD47 contains one
extracellular Ig variable domain (IgV) followed by ﬁve pre-
dicted transmembrane segments terminating in a cytoplasmic
tail. MFR/SIRPa contains one extracellular amino-terminal
IgV domain and two adjacent immunoglobulin constant (IgC1)
domains. A lower-molecular-weight form of MFR/SIRPa
(MFR-s) lacks the C1 domains and contains only the V do-
main (Fig. 4). The IgV loop of CD47 binds to the IgV domain
of both forms of MFR/SIRPa, an interaction that is likely
blocked by monoclonal antibodies to MFR/SIRPa. An inter-
esting hypothesis is that during fusion, CD47 binds ﬁrst to
the long form of MFR/SIRPa, to secure the recognition/
attachment of macrophages, and then switches to the short
form of MFR to bring apposed plasma membranes closer to
one another. Upon binding of CD47 to the short form of
MFR/SIRPa and possible bending of CD47-MFR’s IgV do-
mains, the distance between the plasma membranes of adjacent
cells could be reduced to 5–10 nm, which might increase the
probability of spontaneous fusion.
Another interesting hypothesis is that CD47, which is related
to proteins expressed by Vaccinia and Variola viruses [105],
promotes Ca2+ entry into fusing partners, like A38L does, pos-
sibly by forming a pore [106]. Indeed, as discussed earlier, pore
formation is used by yeast cells to mate and myoblasts to form
multinucleate muscle cells [17,69]. Likewise, the overexpression
Fig. 4. Hypothetical mechanism for fusion of macrophages. Macro-
phage–macrophage recognition/adhesion is achieved by binding of
MFR/SIRPa to CD47. The stepwise association of the long form of
MFR and then the short form of MFR (MFR-s) with CD47 reduces
the distance between the plasma membranes. The shedding of the
extracellular domain of MFR might facilitate this association (Cui and
Vignery, unpublished observation). The distance between macrophage
plasma membranes could be reduced to 5–10 nm if MFR-s and CD47
bend upon binding. Meanwhile, the extracellular domain of CD44 also
sheds, further facilitating plasma membranes from opposite cells to get
closer, and fuse. In addition, the intracellular domain of CD44 is
cleaved by a gamma secretase complex and translocates to the nucleus
to promote the activation of NF-jB. NF-jB is a transcription factor
that is indispensable for osteoclastogenesis. DC-STAMP, upon acti-
vation by its (unknown) ligand, regulates fusion.
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sibility that once the membranes from opposite cells are closely
apposed and stable, CD47 molecules may create a pore that
triggers cell–cell fusion. Although this last possibility is highly
speculative, it opens an interesting avenue of research. In sup-
port of the MFR/SIRPa-CD47 hypothesis, a recent report
indicates that osteoclast formation is strongly reduced in the
absence of CD47-MFR/SIRPa-interaction [108].Similarly to MFR/SIRPa, the expression of CD44, the
receptor for hyaluronan, is strongly and transiently induced
at the onset of macrophage fusion, which suggests a role in fu-
sion [109]. While no cell surface ligand for CD44 has been
identiﬁed, the fate of CD44 during the fusion of macrophages
has recently been elucidated. It was known that the extracellu-
lar domain of CD44, which is cleaved by MT1-MMP, sheds
from the plasma membrane. The extracellular domain of
CD44 shedding from the plasma membrane might allow oppo-
site macrophage plasma membranes to entertain a closer inter-
action, and to facilitate their fusion [110]. In addition,
following the shedding of the extracellular domain of CD44,
its intracellular domain is cleaved by presenilin, which belongs
to a large enzymatic complex called ‘‘gamma secretase’’. CD44
intracellular domain translocates to the nucleus to promote the
activation of the transcription factor NF-jB, which is required
for the diﬀerentiation of osteoclasts. Interestingly, the extracel-
lular domain of MFR/SIRPa also sheds from the plasma
membrane of macrophages during fusion (Cui and Vignery,
unpublished observation).
Additional cell surface molecules that might also play a role
in macrophage attachment leading to fusion include CD9 and
CD81, which, like C. elegans SPE-38, are tetraspan membrane
proteins [111]. Cadherin and the purigenic receptor P2X7 ap-
pear to facilitate the fusion of macrophages into osteoclasts
and giant cells, respectively [112,113], although P2X7 receptor
knockout mice show normal osteoclasts [114]. Inhibitors of
mannose receptor expression prevent macrophage fusion
in vitro [115], and beta1 and beta2 integrins mediate the adhe-
sion of macrophages at the onset of fusion [116]. Although
each one of these molecules might participate at some level
in cell–cell recognition and/or attachment, none is required
for fusion.
The most dramatic observation has been DC-STAMP,
which was reported recently to be required for the fusion of
macrophages [117]. Mice that lack DC-STAMP lack multinu-
cleate osteoclasts and giant cells, and develop a mild form of
osteopetrosis. Because DC-STAMP is a seven-transmembrane
receptor, it is reminiscent of CXCR4, the co-receptor for HIV
that is required for fusion, and of yeast Ste2 and Ste3, G-pro-
tein coupled receptors responsible for the initiation of fusion.
Ligation of DC-STAMP, by a yet unknown ligand, might reg-
ulate rather than mediate fusion. While a larger number of un-
knowns surround DC-STAMP, the question of whether DC-
STAMP interacts with, or regulates the expression of MFR/
SIRPa-CD47 and CD44 remains open.
Most recently, mice that lack the V-ATPase Vo subunit d2
were reported to exhibit impaired osteoclast fusion [118].
Hence, in contrast with C.elegans, the V-ATPase favors fusion
in macrophages such that mice that lack V-ATPase Vo subunit
d2 develop a mild form of osteopetrosis.
While the question of whethermacrophages fuse with somatic
cells for repair, and cancer cells for metastasis has been recently
discussed, and remains open [103,119], the actual molecular
mechanics of macrophage fusion remain poorly understood. In-
deed, unlike viruses, which often contain one protein in their
coat, plasma membranes from cells are rich in proteins, integral
and membrane-associated, which are themselves modiﬁed post-
translationally and decorated by lipids and sugar moieties. The
level of complexity of plasma membrane proteins, complicated
by their intracellular domain, which transduces signals down-
stream, suggests that the cell–cell fusion machinery is more
2190 E.H. Chen et al. / FEBS Letters 581 (2007) 2181–2193complex than originally anticipated and that its members might
act in a sequential manner to secure fusion. The need for cell–
cell recognition, then attachment, and ﬁnally fusion, in addition
to regulatory mechanisms like DC-STAMP, leads us to believe
that we are at the very beginning of understanding the mechan-
ics of macrophage fusion.6. Conclusion
Cell–cell fusion emerged as a new ﬁeld of research subse-
quent to major advances in our understanding of the molecu-
lar mechanisms of membrane fusion. It has become clear that
fusion of viruses with host cells and of intracellular membranes
during traﬃcking is mediated by a set of proteins that are spe-
ciﬁc to each type of fusing cell and each type of membrane,
respectively. However, the molecular mechanisms that mediate
cell–cell fusion remain largely unknown, and the fusion
machinery remains to be characterized. Nonetheless, some
common aspects have become apparent as cells must follow
a well-ordered ritual in order to fuse. First, cells that are des-
tined to fuse send oﬀ signals to enter a ‘‘prefusion’’ state. These
prefusion signals can be reciprocal, like the a- and a- mating
pheromones in yeast, or asymmetric, as in the case of DC-
STAMP in macrophages. Next, adhesive interactions form be-
tween the plasma membranes of the two fusion partners. In
yeast, membrane contact is promoted by turgor pressure with-
in a pair of cells held in place by a common cell wall. In Dro-
sophila myoblast fusion and mammalian macrophage fusion,
members of the IgSF mediate adhesion and also initiate exten-
sive intracellular signaling events. Ultimately, fusion partners
actively engage in interactions via specialized transmembrane
proteins. These interactions can be homotypic and directly
trigger fusion, exempliﬁed by the C. elegans fusogen EFF-1,
or, as in the case of yeast Prm-1, they can stabilize the appos-
ing membranes as they fuse.
We anticipate that future studies will uncover new factors
that participate in various cell–cell fusion processes and lead
to a richer understanding of membrane fusion mechanisms.
This work promises to provide new insights into diseases, such
as osteopetrosis, in which normal cell fusion is disrupted, and
lead to potential treatment of degenerative diseases like muscu-
lar dystrophy through myoblast fusion-based cell therapy.
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